← All trials
NCT01440140
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2012
- Primary completion
- Dec 31, 2013
- Completion date
- Jan 31, 2014
- First posted
- Sep 26, 2011
- Last posted
- Jan 29, 2014
- Enrollment
- 24
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of CambridgeLead sponsor
- Diabetes UKCollaborator
- University of CambridgeOverall official - principal investigator
- University of CambridgeReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.